Related Experiment Video
Updated: Apr 6, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients
Bahar Naghavi Gargari1, Mehrdad Behmanesh1, Zeinab Shirvani Farsani1
1Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Abstract:
Vitamin D regulates gene expression and affects target cell functions. IL-6 and IL-17A are pro-inflammatory cytokines associated with MS pathogenesis. The aim of this study was to investigate the vitamin D effects on the expression level of IL-6 and IL-17A in peripheral blood mononuclear cells (PBMCs) of multiple sclerosis (MS) patients. Also, we performed a correlation analysis between the gene expression and some clinical features such as serum level of vitamin D and the expanded disability status scale (EDSS). Significant up-regulation of IL-6 and IL-17A gene expression was shown under vitamin D treatment. Also, some gender specific correlations between the gene expression with vitamin D levels were detected in female RR-MS patients.
Insights
Vitamin D treatment increased pro-inflammatory gene expression (IL-6 and IL-17A) in multiple sclerosis (MS) patients. Correlations were found between gene expression, vitamin D levels, and clinical features, particularly in female RR-MS patients.
Area of Science:
- Immunology
- Neuroscience
- Endocrinology
Background:
- Vitamin D plays a crucial role in regulating gene expression and cellular functions.
- Interleukin-6 (IL-6) and Interleukin-17A (IL-17A) are key pro-inflammatory cytokines implicated in the pathogenesis of Multiple Sclerosis (MS).
Purpose of the Study:
- To investigate the impact of vitamin D on the expression levels of IL-6 and IL-17A in peripheral blood mononuclear cells (PBMCs) from MS patients.
- To analyze correlations between these gene expressions and clinical indicators, including serum vitamin D levels and the Expanded Disability Status Scale (EDSS).
Main Methods:
- Culturing PBMCs from MS patients.
- Treating PBMCs with vitamin D.
- Quantifying IL-6 and IL-17A gene expression.
- Performing correlation analyses with clinical data (serum vitamin D, EDSS).
Main Results:
- Vitamin D treatment led to a significant upregulation of IL-6 and IL-17A gene expression in MS patient PBMCs.
- Specific gender-based correlations were observed between gene expression levels and serum vitamin D concentrations in female Relapsing-Remitting MS (RR-MS) patients.
Conclusions:
- Vitamin D influences the expression of pro-inflammatory cytokines IL-6 and IL-17A in the context of MS.
- Findings suggest potential gender-specific interactions between vitamin D status and inflammatory markers in MS, warranting further investigation.

